DE69332758D1 - Taxol zur behandlung von lymphomen und brustkrebs und zur verminderung der multi-drug resistenz gegen taxol - Google Patents

Taxol zur behandlung von lymphomen und brustkrebs und zur verminderung der multi-drug resistenz gegen taxol

Info

Publication number
DE69332758D1
DE69332758D1 DE69332758T DE69332758T DE69332758D1 DE 69332758 D1 DE69332758 D1 DE 69332758D1 DE 69332758 T DE69332758 T DE 69332758T DE 69332758 T DE69332758 T DE 69332758T DE 69332758 D1 DE69332758 D1 DE 69332758D1
Authority
DE
Germany
Prior art keywords
taxol
breast cancer
drug resistance
patient
reducing multi
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69332758T
Other languages
English (en)
Inventor
Wyndham H Wilson
Robert Wittes
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
US Department of Health and Human Services
Original Assignee
US Department of Health and Human Services
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by US Department of Health and Human Services filed Critical US Department of Health and Human Services
Application granted granted Critical
Publication of DE69332758D1 publication Critical patent/DE69332758D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE69332758T 1992-09-22 1993-09-22 Taxol zur behandlung von lymphomen und brustkrebs und zur verminderung der multi-drug resistenz gegen taxol Expired - Lifetime DE69332758D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US95038092A 1992-09-22 1992-09-22
PCT/US1993/008983 WO1994006422A1 (en) 1992-09-22 1993-09-22 Use of taxol for treating lymphomas and breast cancer

Publications (1)

Publication Number Publication Date
DE69332758D1 true DE69332758D1 (de) 2003-04-17

Family

ID=25490363

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69332758T Expired - Lifetime DE69332758D1 (de) 1992-09-22 1993-09-22 Taxol zur behandlung von lymphomen und brustkrebs und zur verminderung der multi-drug resistenz gegen taxol

Country Status (8)

Country Link
US (2) US5496846A (de)
EP (1) EP0661969B1 (de)
JP (1) JP3020277B2 (de)
AT (1) ATE234088T1 (de)
AU (1) AU680441B2 (de)
CA (1) CA2145190A1 (de)
DE (1) DE69332758D1 (de)
WO (1) WO1994006422A1 (de)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5886026A (en) * 1993-07-19 1999-03-23 Angiotech Pharmaceuticals Inc. Anti-angiogenic compositions and methods of use
US7307198B2 (en) 1995-08-31 2007-12-11 Roslin Institute Ungulates produced by nuclear transfer of G1 cells
GB2318792B (en) * 1995-08-31 2000-06-21 Roslin Inst Unactivated oocytes as cytoplast recipients for nuclear transfer
GB9517779D0 (en) 1995-08-31 1995-11-01 Roslin Inst Edinburgh Biological manipulation
GB9517780D0 (en) * 1995-08-31 1995-11-01 Roslin Inst Edinburgh Biological manipulation
CN1219872A (zh) 1996-05-24 1999-06-16 血管技术药物公司 治疗或预防身体通道疾病的组合物和方法
US5821263A (en) * 1996-08-26 1998-10-13 Bristol-Myers Squibb Company Sulfenamide taxane derivatives
US6495579B1 (en) 1996-12-02 2002-12-17 Angiotech Pharmaceuticals, Inc. Method for treating multiple sclerosis
US20030157187A1 (en) * 1996-12-02 2003-08-21 Angiotech Pharmaceuticals, Inc. Compositions and methods for treating or preventing inflammatory diseases
US6515016B2 (en) 1996-12-02 2003-02-04 Angiotech Pharmaceuticals, Inc. Composition and methods of paclitaxel for treating psoriasis
US7361804B1 (en) 1997-02-19 2008-04-22 Roslin Institute (Edinburgh) Unactivated oocytes in nuclear transfer to produce ungulates
JP3896435B2 (ja) * 1997-12-17 2007-03-22 アークレイ株式会社 センサおよびセンサ集合体
AU756752B2 (en) * 1998-04-01 2003-01-23 Skyepharma Canada Inc. Anticancer compositions
AU777528B2 (en) * 1999-04-22 2004-10-21 Abraxis Bioscience, Llc Long term administration of pharmacologically active agents
EP1685835A3 (de) * 1999-04-22 2006-08-09 American Bioscience, Inc. Langzeitapplikation subtherapeutischer Mengen pharmakologischer Wirkstoffe
US6294546B1 (en) 1999-08-30 2001-09-25 The Broad Of Trustees Of The Leland Stanford Junior University Uses of diterpenoid triepoxides as an anti-proliferative agent
US6569459B2 (en) 2000-04-10 2003-05-27 Teva Pharmaceutical Industries, Ltd. Method of administration of paclitaxel-plasma protein formulation
US6410059B1 (en) * 2000-10-20 2002-06-25 Council Of Scientific And Industrial Research Pharmaceutical composition containing cow urine distillate and an antibiotic
CZ294371B6 (cs) * 2002-06-10 2004-12-15 Pliva - Lachema, A. S. Stabilizovaná farmaceutická kompozice na bázi polyoxyethylovaného ricinového oleje a způsob její přípravy
WO2005072779A2 (en) * 2004-01-27 2005-08-11 University Of South Florida Growth factor-binding compounds attached to a calixarene
CA2556589A1 (en) * 2004-02-24 2005-09-01 Bioaxone Therapeutique Inc. 4-substituted piperidine derivatives
US7989490B2 (en) * 2004-06-02 2011-08-02 Cordis Corporation Injectable formulations of taxanes for cad treatment
US7459562B2 (en) * 2004-04-23 2008-12-02 Bristol-Myers Squibb Company Monocyclic heterocycles as kinase inhibitors
US20060252823A1 (en) * 2005-05-04 2006-11-09 Deck Lorraine M Isocoumarin-based inhibitors of urokinase-type plasminogen activator
US9517240B2 (en) 2006-09-26 2016-12-13 The Regents Of The University Of California Methods and compositions for cancer prevention and treatment
WO2008039482A2 (en) * 2006-09-26 2008-04-03 The Regents Of The University Of California Methods and compositions for cancer prevention and treatment
US20080227853A1 (en) * 2007-03-13 2008-09-18 Bionature E. A. Limited Androgene membrane receptor agonist
US8403291B2 (en) * 2007-06-21 2013-03-26 Michael Wallace Howlett Tube slide clamp with extending finger grips
FR2933405B1 (fr) * 2008-07-03 2010-08-13 Centre Nat Rech Scient Derives ferroceniques a activite anticancereuse
US10149856B2 (en) 2015-01-26 2018-12-11 BioAxone BioSciences, Inc. Treatment of cerebral cavernous malformations and cerebral aneurysms with rho kinase inhibitors
US10857157B2 (en) 2015-01-26 2020-12-08 BioAxone BioSciences, Inc. Treatment of cerebral cavernous malformations and cerebral aneurysms with rho kinase inhibitors
US10106525B2 (en) 2015-01-26 2018-10-23 BioAxone BioSciences, Inc. Rho kinase inhibitor BA-1049 (R) and active metabolites thereof
US11198680B2 (en) 2016-12-21 2021-12-14 BioAxone BioSciences, Inc. Rho kinase inhibitor BA-1049 (R) and active metabolites thereof
WO2019014322A1 (en) 2017-07-11 2019-01-17 BioAxone BioSciences, Inc. KINASE INHIBITORS FOR THE TREATMENT OF DISEASES

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6630454B2 (en) * 2001-09-10 2003-10-07 Ramot At Tel-Aviv University Ltd. Method and pharmaceutical composition for the treatment of cancer

Also Published As

Publication number Publication date
US5496846A (en) 1996-03-05
AU680441B2 (en) 1997-07-31
USRE40839E1 (en) 2009-07-07
EP0661969B1 (de) 2003-03-12
JPH08501560A (ja) 1996-02-20
ATE234088T1 (de) 2003-03-15
AU5135793A (en) 1994-04-12
CA2145190A1 (en) 1994-03-31
EP0661969A1 (de) 1995-07-12
JP3020277B2 (ja) 2000-03-15
WO1994006422A1 (en) 1994-03-31

Similar Documents

Publication Publication Date Title
DE69332758D1 (de) Taxol zur behandlung von lymphomen und brustkrebs und zur verminderung der multi-drug resistenz gegen taxol
DE3684190D1 (de) Verwendung von tetrahydrobiopterinen zur herstellung eines medikaments zur behandlung von kinderautismus.
DE69213814D1 (de) Melatoninderivate zur Behandlung von Schlafstörungen und zur Pre-Anästhesie
KR900015730A (ko) 정신장해 치료방해
DE10199020I2 (de) Galanthamin oder dessen Analoge zur Behandlung derAlzheimerschen Krankheit.
IL107109A0 (en) Compounds for modifying drug resistance and pharmaceutical compositions containing the same
ATE334668T1 (de) Pharmazeutische zusammensetzung zur behandlung von neurologischen und neuropsychiatrischen erkrankungen
ATE144420T1 (de) Verwendung von riluzol zur behandlung von parkinson und den parkinson-syndromen
DK0668763T3 (da) Anvendelse af phenserin til fremstillingen af lægemidler til behandlingen af kognitive sygdomme
DE69012261D1 (de) Verwendung von Sertralin zur Behandlung verfrühter Ejakulation.
DE69825279D1 (de) Verwendung von glukosamin und glukosaminderivaten zur schnellen linderung von juckreiz oder lokalisiertem schmerz
DE59605959D1 (de) Verwendung von Immunglobulin-Präparationen zur Herstellung eines Medikaments zur oralen Verabreichung zur Behandlung und Prophylaxe chronischer Schmerzzustände
KR890003390A (ko) 골다공증 및 관련된 장해의 치료방법
MXPA00010254A (es) Tratamiento de disfuncion sexual en ciertos grupos de pacientes.
DE69924483D1 (de) Kombinationstherapie zur behandlung von tumoren
ATE141796T1 (de) 2',5'-oligoadenylat-derivate zur verwendung als heilmittel
KR890000108A (ko) 종양 치료용 약제학적 조성물
HUP9903679A2 (hu) Olanzapin alkalmazása bipoláris zavar kezelésére szolgáló gyógyszerkészítmények előállítására
DE69010523D1 (de) Kit oder Zusammensetzung zur Vorbeugung oder Behandlung von HIV-1 Infektionen.
DE68909750T2 (de) Vorrichtung zur therapeutischen behandlung von lumbago sowie lumbago/ischias.
KR900017599A (ko) 종양 치료용 약학 조성물
ATE295731T1 (de) Olanzapine zur behandlung von drogenmissbrauch
ATE271867T1 (de) Behandlung der harninkontinenz und zusammenstellung dafür
DE69528068T2 (de) Conagenine zur prävention und behandlung von diarrhöe
DE59813136D1 (de) Verwendung von Thiaminen zur Herstellung eines Arzneimittels zur Prophylaxe und zur Therapie der diabetischen Retinopathie und der diabetischen Nephropathie

Legal Events

Date Code Title Description
8332 No legal effect for de